| Entry |
|
|---|
| Name |
Nevadistinel (USAN) |
|---|
| Formula |
C15H18N2O3
|
|---|
| Exact mass |
274.1317
|
|---|
| Mol weight |
274.315
|
|---|
| Structure |
|
|---|
| Efficacy |
Dementia therapeutic agent, NMDA receptor modulator |
|---|
| Comment |
Treatment of cognitive impairments in Parkinson's disease and dementia
|
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
| hsa05022 | Pathways of neurodegeneration - multiple diseases |
|
|---|
| Brite |
Target-based classification of drugs [BR:br08310]
Ion channels
Ligand-gated ion channels
Glutamate (ionotropic), NMDA
GRIN (NMDAR)
D12553 Nevadistinel (USAN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 20
1 C1z C 6.6500 -6.5100
2 C1x C 5.9500 -5.3200
3 C1x C 4.5500 -5.3200
4 N1x N 3.8500 -6.5100
5 C5x C 4.5500 -7.7000
6 C1x C 5.9500 -7.7000
7 C1x C 7.6300 -5.5300
8 C5x C 7.6300 -7.4900
9 N1y N 8.6100 -6.5100
10 C1b C 10.0100 -6.5100
11 C8y C 10.7100 -7.7224
12 C8x C 10.0196 -8.9179
13 C8x C 10.7195 -10.1304
14 C8y C 12.1195 -10.1306
15 C8x C 12.8099 -8.9351
16 C8x C 12.1100 -7.7226
17 O2a O 12.8254 -11.3534
18 C1a C 14.2099 -11.3532
19 O5x O 7.6300 -8.8900
20 O5x O 3.8549 -8.9153
BOND 22
1 1 2 1
2 2 3 1
3 3 4 1
4 4 5 1
5 5 6 1
6 1 6 1
7 1 7 1 #Up
8 1 8 1 #Down
9 8 9 1
10 7 9 1
11 9 10 1
12 10 11 1
13 11 12 2
14 12 13 1
15 13 14 2
16 14 15 1
17 15 16 2
18 11 16 1
19 14 17 1
20 17 18 1
21 8 19 2
22 5 20 2
|
|---|
